Lakefront Biotherapeutics (LKFT) Exchange Rate Effect (2016 - 2026)
Lakefront Biotherapeutics (LKFT) posted quarterly Exchange Rate Effect of $796568.0 for Q1 2026, up 153.89% year-on-year from $313748.3 in Q1 2025, and up 151.97% on a QoQ basis from -$1.5 million in Q4 2025.
Lakefront Biotherapeutics (LKFT) Exchange Rate Effect (2016 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Exchange Rate Effect for 10 consecutive years, with $796568.0 the latest figure, recorded in Q1 2026.
- Quarterly Exchange Rate Effect rose 153.89% year-over-year to $796568.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 15256.25% YoY) and the FY2025 annual result came in at -$5.1 million, down 350.06% from the prior year.
- Exchange Rate Effect advanced to $796568.0 in Q1 2026 per LKFT's latest filing, from -$1.5 million in the prior quarter.
- Over the last five years, Exchange Rate Effect for LKFT reached as high as $18.6 million in Q1 2022 and fell as low as -$4.2 million in Q4 2022.
- A 5-year average of $830006.3 and a median of -$289040.4 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect jumped 296.46% — and 2025, when it sank 491.82%.
- Year by year, Exchange Rate Effect stood at -$4.2 million in 2022, then soared by 75.49% to -$1.0 million in 2023, then surged by 245.25% to $1.5 million in 2024, then plunged by 201.35% to -$1.5 million in 2025, then surged by 151.97% to $796568.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $796568.0, -$1.5 million, and -$97864.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn | 796,567.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 796,567.99 |
| Mar 31, 2026 | 796,567.99 |
| Dec 31, 2025 | -1.53 Mn |
| Dec 31, 2025 | -1.53 Mn |
| Sep 30, 2025 | -97,864.07 |
| Sep 30, 2025 | -97,864.07 |
| Jun 30, 2025 | -1.96 Mn |
| Jun 30, 2025 | -1.96 Mn |
| Mar 31, 2025 | -1.48 Mn |
| Mar 31, 2025 | -1.48 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | -553,045.78 |
| Sep 30, 2024 | -553,045.78 |
| Jun 30, 2024 | 500,699.88 |
| Jun 30, 2024 | 500,699.88 |
| Mar 31, 2024 | 567,839.18 |
| Mar 31, 2024 | 567,839.18 |
| Dec 31, 2023 | -1.04 Mn |
| Dec 31, 2023 | -1.04 Mn |